-1.png)
The status of drug discovery and development for Alzheimer's disease

Research highlights: Target identification to modulate neuroinflammation in Alzheimer’s disease

Case Study: Modeling Friedreich’s ataxia using patient-derived iPSCs

Adoption of complex disease modeling brings new optimism and hope to drug discovery

White paper: Advancing drug discovery for neurodegenerative diseases

Research highlights: iPSCs for gene therapy development